- Plan is backed by $4bn from Sackler family
- Most parties onboard but Democratic attorneys general oppose
Purdue Pharma is proposing a $10bn plan to emerge from bankruptcy that calls for it to be transformed into a company funnelling profits into the fight against the opioid crisis.
Those efforts would include a significant boost – more than $4bn – from members of the Sackler family who own the Connecticut-based pharmaceutical giant.
